Connect with us
CGIF-10th-Year-Anniversary

Health

Thailand hopes to produce COVID-19 vaccine next year

The vaccine, developed by Thai researchers, is an MRNA vaccine designed to help the body create immunity against the new coronavirus could be available as early as next year.

National News Bureau of Thailand

Published

on

BANGKOK (NNT) – Thai researchers have completed a trial of a potential COVID-19 vaccine with rats, to be followed by a trial in monkeys. The team coordinated with North American manufacturers to produce the first batch of the vaccine.

The Center for COVID-19 Situation Administration (CCSA) spokesman Dr Taweesin Visanuyothin, said yesterday regarding the development of a potential vaccine against COVID-19 in Thailand, that the vaccine had passed its trial in rats, with the next step being a trial in monkeys.

The vaccine, developed by Thai researchers, is an MRNA vaccine designed to help the body create immunity against the new coronavirus. It could be available as early as next year, provided that all tests are successful. The Prime Minister and Minister of Defence, Gen Prayut Chan-o-cha, has ordered the development to progress urgently.

Dr Taweesin said, “Chulalongkorn University’s Vaccine Research Center has joined forces with the National Vaccine Institute and the Department of Medical Sciences in this vaccine development, in which initial tests on lab rats have been successful. The vaccine will be tested on monkeys next week.

The Minister of Higher Education said the Prime Minister has ordered the project to move along urgently, ensuring that Thailand would be among the first countries to have a vaccine available.

“This is good news for Thai people, and deserving of praise for Thai scientists.”

CCSA spokesman said today that researchers have coordinated with manufacturers in the U.S. and Canada to produce the first batch of the vaccine, which will be used in clinical trials with human volunteers.

Thai researchers started COVID-19 vaccine monkey trials

After a promising outcome from trials in rats, an anti-virus vaccine prototype developed by Thai researchers is now being tested in monkeys, with the results expected by September.

Researchers from the National Research Council of Thailand, the National Vaccine Institute, and Chulalongkorn University today started the trial of the mRNA vaccine prototype for COVID-19 at Chulalongkorn University’s National Primate Research Center of Thailand in Saraburi.

In the trial, the vaccine will be given in various doses to 13 female cynomolgus monkeys aged 4-6 years, which are comparable to humans aged 12 years or older.

Comments

Companies

Thai Firm to produce 200 million doses of Covid-19 vaccine

Thai Firm Siam Bioscience Joins with AstraZeneca to Make COVID-19 Vaccine for Southeast Asia and says it will produce 200 million doses of its anti-coronavirus vaccine in Thailand next year.

Olivier Languepin

Published

on

Thailand aims to vaccinate up to half of its population against Covid-19 next year according to the director of its National Vaccine Institute, Dr. Nakorn Premsri.

(more…)
Continue Reading

Health

The Latest on Covid-19 in Southeast Asia

Even in Southeast Asia, which has fared comparatively well in minimizing deaths, economies have either ground to a halt or deeply contracted due to the region’s reliance on exports and tourism.

Pr News

Published

on

By

It would be an understatement to describe 2020 as a challenging year. Coronavirus swept the globe and over 1.6 million people have died from the disease.

(more…)
Continue Reading

Health

Covid-19 is not the biggest health crisis in Thailand

For many years, Thailand has earned notoriety in the area of road fatalities: Thailand’s roads are the deadliest in Southeast Asia and among the worst in the world, according to the World Health Organisation

Avatar

Published

on

If we go by the number of deaths, the coronavirus is not the country’s biggest health public health problem. Road accidents are.

(more…)
Continue Reading
Advertisement

Latest

Most Viewed

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

Join 13,413 other subscribers

Trending